Q. Feng

Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with increased mitochondrial membrane potential.

P. Leppert, T. Price, Q. Dai, 2014, The Journal of clinical endocrinology and metabolism.

[Expression of hSef and FGF-2 in epithelial ovarian tumor].

Huirong Shi, J. Zhao, Q. Feng, 2011, Zhonghua zhong liu za zhi [Chinese journal of oncology].

Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism

S. Cui, Q. Feng, Lindong Zhang, 2019, Bioscience reports.

Sunitinib as first-line neoadjuvant therapy in two patients with rectal stromal tumors.

Q. Feng, Y. Xiang, Jia Ruipeng, 2013, Future oncology.

Incidence and significance of psammoma bodies in Xp 11 . 2 translocation renal cell carcinoma and papillary renal cell carcinoma

Jun Yang, Hongqian Guo, X. Linfeng, 2019 .